Gallagher, Katherine E.

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., et al. (2021) · Science

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 328

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Whitworth, H. S., Gallagher, K. E., Howard, N., Mounier-Jack, S., Mbwanji, G., Kreimer, A. R., Basu, P., Kelly, H., Drolet, M., Brisson, M., et al. (2020) · Vaccine

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 118

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya

Adetifa, I. M. O., Uyoga, S., Gitonga, J. N., Mugo, D., Otiende, M., Nyagwange, J., Karanja, H. K., Tuju, J., Wanjiku, P., Aman, R., et al. (2021) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 67

Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) associated with childhood pneumonia in Kilifi, Kenya

Otieno, G. P., Murunga, N., Agoti, C. N., Gallagher, K. E., Awori, J. O., & Nokes, D. J. (2020) · Wellcome Open Research

Respiratory viral infections researchPneumonia and Respiratory Infections

Cited by 20